Hypofractionated 3D radiotherapy for inoperable T1-3 N0-1 non-small-cell lung cancer. - Wikidata - awgldk - TriplyDB

Hypofractionated 3D radiotherapy for inoperable T1-3 N0-1 non-small-cell lung cancer.

Hypofractionated 3D radiotherapy for inoperable T1-3 N0-1 non-small-cell lung cancer.

http://www.wikidata.org/entity/Q37601085

about

Hypofractionated 3D radiotherapy for inoperable T1-3 N0-1 non-small-cell lung cancer.

http://www.wikidata.org/entity/Q37601085

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 March 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Hypofractionated 3D radiotherapy for inoperable T1-3 N0-1 non-small-cell lung cancer.

@en

Hypofractionated 3D radiotherapy for inoperable T1-3 N0-1 non-small-cell lung cancer.

@nl

type

label

Hypofractionated 3D radiotherapy for inoperable T1-3 N0-1 non-small-cell lung cancer.

@en

Hypofractionated 3D radiotherapy for inoperable T1-3 N0-1 non-small-cell lung cancer.

@nl

prefLabel

Hypofractionated 3D radiotherapy for inoperable T1-3 N0-1 non-small-cell lung cancer.

@en

Hypofractionated 3D radiotherapy for inoperable T1-3 N0-1 non-small-cell lung cancer.

@nl

P1433

Q37601085-48C2162E-4CEF-4C05-A122-F3B6733A33F3

P1476

Q37601085-00332436-0DDD-4450-A85A-5A92039307D4

P2093

Q37601085-2163F5FA-4127-405B-8222-C6BFDA9D4EC8

Q37601085-61D9AABE-D4F1-4598-9901-0F028040FF76

Q37601085-8438D666-27BF-425E-97C2-3E7450334C72

Q37601085-A2F157F4-AAF8-4E18-8145-D26B3877D36E

Q37601085-AE476F8C-38BB-4391-80E0-8ECAED2DE485

Q37601085-C654CBF8-3B8B-483F-AE1F-DA8EB6D1EED2

Q37601085-D1081CAB-F1BE-4E3A-B295-2BDD15211ACE

P2860

Q37601085-0141D65F-F93E-432D-B21C-A8476A5F958C

Q37601085-02E85B3C-5FBD-4DCB-A712-66E4A7E3DBCE

Q37601085-3519F612-AD47-4D3E-8FA0-069C70DE2CDB

Q37601085-4D2EE0E4-A4EB-4853-AE1A-47309E3C4654

Q37601085-566A9AF0-11A9-47F8-AD0D-2CC2EE78E7A3

Q37601085-5BC5F9A2-ED54-4BED-9638-B4F59FF3AC31

Q37601085-6BE2F618-9984-4C3E-99EB-F74CA8E18CBD

Q37601085-74426C55-F9C1-4A39-816E-6256A1B76862

Q37601085-7B049AAC-697E-411C-8228-AB3CBBB295E1

Q37601085-86C0D9E5-908D-4366-ABC4-CD8AF831624D

P304

Q37601085-06367ED3-8D72-4DB2-A3A1-DB39685CBEBD

P31

Q37601085-F60BA30F-D131-459C-9580-278AE06A66EB

P356

Q37601085-B5C68AF7-F4DE-4CBD-84C2-F74087CA563E

P407

Q37601085-8963E42B-A8DB-439F-91BC-6F8CAAC29E42

P433

Q37601085-8E8976A3-C3C6-480E-92DA-9CB4C2DA8C67

P478

Q37601085-4F951DC4-894A-415C-A6A5-9D80C6040150

P50

Q37601085-540251D5-B1F2-4CAC-8053-A61CA6FB9BF1

P577

Q37601085-6A92EB0B-472F-4BB1-84B3-9C6CF681BAE4

P698

Q37601085-34F43F65-F765-4D5E-BDFB-45640E267581

P921

Q37601085-9EAEFA6E-A46A-4D6A-8362-0BB0D865E809

P932

Q37601085-1E0A0B6A-80F2-41D8-9640-733B611468A3

P356

P1433

British Journal of Radiology

P1476

Hypofractionated 3D radiotherapy for inoperable T1-3 N0-1 non-small-cell lung cancer.

@en

P2093

Alejandro Seoane

http://www.w3.org/2001/XMLSchema#string

Alexandra Giraldo

http://www.w3.org/2001/XMLSchema#string

Jordi Andreu

http://www.w3.org/2001/XMLSchema#string

Jordi Giralt

http://www.w3.org/2001/XMLSchema#string

Marc Simó

http://www.w3.org/2001/XMLSchema#string

Meritxell Mollà

http://www.w3.org/2001/XMLSchema#string

Monica Ramos

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904.

Medically Inoperable Lung Carcinoma: The Role of Radiation Therapy.

Which is the optimal biologically effective dose of stereotactic body radiotherapy for Stage I non-small-cell lung cancer? A meta-analysis.

Stereotactic body radiation therapy for inoperable early stage lung cancer.

Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review

Hypofractionated three-dimensional conformal radiotherapy for medically inoperable early stage non-small-cell lung cancer

Phase II study of accelerated hypofractionated three-dimensional conformal radiotherapy for stage T1-3 N0 M0 non-small cell lung cancer: NCIC CTG BR.25.

P304

20150824

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1259/BJR.20150824

http://www.w3.org/2001/XMLSchema#string

P407

P433

1062

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26986457

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

5258152

http://www.w3.org/2001/XMLSchema#string